Abstract
• Background
Allografts can be rejected either through the antibody-mediated or cellular pathways. The objective of this study was to look at the extent of antibody formation in patients awaiting re-keratoplasty using cross-matches on cadaver retinal pigment epithelial (RPE) cells.
• Methods
CadaverRPE cells were derived by trypsin digestion from donor eyes (n=1200). After 3 days of cell cultivation, the cells were adherent and began to lose their pigment. By day 7 most cells were clear and grew as a polygonal monolayer. MHC class I expression by RPE cells was studied by the W6/32 (anti-HLA-A, B, C) monoclonal antibody (MoAb) and that of class II (HLA-DR) by the 136 MoAb. Normal RPE cells express few class I and no detectable class II antigens. For the induction of MHC expression, cells were subsequently stimulated with 250 U/ml of recombinant gamma interferon for 5 days. Cells were used for tissue typing and also for cross-matches with recipient serum. Cross-matches were subsequently performed and measured by flow cytometry.
• Results
Both class I and class II antigens were strongly enhanced, as could be shown by immunohistochemical staining. Some 20% of those patients awaiting rekeratoplasty (n=60) were positive for anti-HLA antibodies. In one case anti-DR3 antibodies were detected in a recipient who had had several rejection episodes after keratoplasty.
• Conclusions
RPE cells are not only useful for cadaver post-mortem HLA typing but also for donor-specific cross-matches. The degree of antibody formation after keratoplasty in rejecting patients was, however, low. This may imply that anti-HLA antibodies are not the major cause of corneal graft loss after keratoplasty.
Similar content being viewed by others
References
Abi-Hanna D, Wakefield D, Watkins S (1988) HLA antigens in ocular tissues. Transplantation 45:610–613
Barker CF, Billingham RE (1977) Immunologically privileged sites. Adv Immunol 25:1–54
Batchelor JR, Casey TA, Gibbs DC, Lyoyd DF, Werb A, Prasad SS, James A (1976) HLA matching and corneal grafting. Lancet 1:551–554
Beekhuis WH, van Rij G, de Lavalette JGCR, van Driel ER, Persijn G, D'Amaro J (1991) Corneal graft survival in HLA-A and HLA-B matched transplantations in high-risk cases with retrospective review of HLA-DR compatibility. Cornea 10:9–12
Benson JL, Niederkorn JY (1992) Immune privilege in the anterior chamber of the eye: alloantigens and tumorspecific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens. Immunology 77:189–195
Boisjoly HM, Roy R, Laughrea P, Michaud R, Douville P, Hebert J (1986) HLA-A, B and DR matching in corneal transplantation. Ophthalmology 93:1290–1297
CCTS (1992) The collaborative corneal transplantation studies (CCTS). Arch Ophthalmol 110:1392–1403
Chan CC, Detrick B, Nussenblatt RB, Palestine AG, Fujikawa LS, Hooks JJ (1986) HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. Arch Ophthalmol 104:725–729
Daar AS, Fuggle V, Fabre JW, Ting A, Morris PJ (1984) The detailed distribution of MHC class II antigens in normal human organs. Transplantation 38:293–298
Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ (1984) The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 38:287–292
D'Amaro J, Volker-Dieben HJ, Kruit PJ, de Lange P, Schipper R (1991) Influence of pretransplant sensitization on the survival of corneal allografts. Transplant Proc 23:368–372
Hoffmann F, von Keyserlingk HJ, Wiederholt M (1986) Importance of HLA DR matching for corneal transplantation in high risk cases. Cornea 5:139–143
Hopkins KA, Maguire MG, Fink NE, Bias WB (1992) Reproducibility of HLA-A, B, and DR typing using peripheral blood samples: results of retyping in the Collaborative Corneal Transplantation Studies. Hum Immunol 33:122–128
Katami M, White DJG, Watson PG (1989) An analysis of corneal graft rejection in the rat. Transplant Proc 21:3147–3149
Katami M, Lim SML, Kamada N, Davies H ff S, Butcher GW, White DJG, Watson PG (1990) A pure class II disparity does not induce rejection of cornea or heart grafts in the rat. Transplant Proc 22:2200–2201
Nicholls SM, Bradley BB, Easty DL (1991) Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection. Invest Ophthalmol Vis Sci 32:2729–2734
Sonada Y, Streilein JW (1992) Orthothopic corneal transplantation in mice — evidence that the immunogenetic rules of rejection do not apply. Transplantation 54:694–704
Roy R, Boisjoly HM, Wagner E, Langlois A, Bernard PM, Bazin R, Laughrea PA, Dube I (1992) Pretransplant and posttransplant antibodies in human corneal transplantation. Transplantation 54:463–467
Talbot D, Givan AL, Shenton BK, Stratton A, et al. (1990) The prospective value of the preoperative flow cytometric crossmatch assay in renal transplantation. Transplantation 49:809–843
Treseler PA, Sanfilippo F (1986) Relative contribution of major histocompatibility complex antigens to the immunogenicity of corneal allografts. Transplantation 41:508–514
Treseler PA, Foulks GN, Sanfilippo F (1986) The relative immunogenicity of corneal epithelium, stroma, and endothelium: the role of major histocompatibility complex antigens. Transplantation 41:229–234
Wilbanks GA, Mammolenti M, Streilein JW (1991) Studies of the induction of anterior chamber-associated immune deviation (ACAID). J Immunol 146:3018–3024
Zavazava N, Halene M, Westphal E, Nölle B, Duncker G, Eckstein V, Harprecht J, Müller-Ruchboltz W (1991) Expression of MHC class I and class II molecules by cadaver retinal pigment epithelium cells: optimization of post-mortem HLA typing. Clin Exp Immunol 84:163–166
Zavazava N, Westphal E, Duncker G, Nölle B, Müller-Ruchholtz W (1992) Post-mortem tissue typing of retinal pigment epithelial cells. Scand J Immunol 36 [Suppl 11]:192–194
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zavazava, N., Nölle, B., Duncker, G. et al. Cross-matches on donor cadaver retinal pigment epithelial cells in corneal risk patients. Graefe's Arch Clin Exp Ophthalmol 234, 164–170 (1996). https://doi.org/10.1007/BF00462028
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00462028